Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression

• Status: Completed
• Trial end date: 2005-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purposes of this study are to determine:

• The safety of duloxetine and any side effects that might be associated with it.

• How duloxetine compares to escitalopram and placebo (an inactive ingredient)

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Citalopram; Dexetimide; Duloxetine Hydrochloride

Criteria

Inclusion Criteria:

• Must be at least 18 of age

• Must meet the criteria for major depressive disorder

• You must be able to visit the doctor's office about once a week for 2 to 3 months. After that, you will need to visit the doctor's office once a month for about 6 months

• You must be able to take the study drug as prescribed (6 capsules per day taken once-daily)

Exclusion Criteria:

• You are a woman and are pregnant or breastfeeding.

• You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder.

• You have a history of alcohol or drug dependence within the past 6 months